6 Einträge gefunden

1. Heterogeneity and chronology of PTEN deletion and ERG fusion in prostate cancer

   1. Krohn, Antje
   2. Freudenthaler, Fabian
   3. Harasimowicz, Silvia
   4. Kluth, Martina
   5. Fuchs, Sarah
   6. Burkhardt, Lia
   7. Stahl, Phillip

   2014 - Forschungsinformationssystem des UKE
2. Clinical significance of different types of p53 gene alteration in surgically treated prostate cancer

   1. Kluth, Martina
   2. Harasimowicz, Silvia
   3. Burkhardt, Lia
   4. Grupp, Katharina
   5. Krohn, Antje
   6. Prien, Kristina
   7. Gjoni, Jovisa

   2014 - Forschungsinformationssystem des UKE
3. Loss of pSer2448-mTOR expression is linked to adverse prognosis and tumor progression in ERG-fusion-positive cancers.

   1. Müller, Juliane
   2. Ehlers, Arne
   3. Burkhardt, Lia
   4. Sirma, Hüseyin
   5. Steuber, Thomas
   6. Graefen, Markus
   7. Sauter, Guido

   2013 - Forschungsinformationssystem des UKE
4. CHD1 is a 5q21 tumor suppressor required for ERG rearrangement in prostate cancer

   1. Burkhardt, Lia
   2. Fuchs, Sarah
   3. Krohn, Antje
   4. Masser, Sawinee
   5. Mader, Malte
   6. Kluth, Martina
   7. Bachmann, Frederik

   2013 - Forschungsinformationssystem des UKE
5. Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressive ERG fusion-positive prostate cancers

   1. Krohn, Antje
   2. Seidel, Annemarie
   3. Burkhardt, Lia
   4. Bachmann, Frederic
   5. Mader, Malte
   6. Grupp, Katharina
   7. Eichenauer, Till

   2013 - Forschungsinformationssystem der UHH
6. Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressive ERG fusion-positive prostate cancers

   1. Krohn, Antje
   2. Seidel, Annemarie
   3. Burkhardt, Lia
   4. Bachmann, Frederik
   5. Mader, Malte
   6. Grupp, Katharina
   7. Eichenauer, Till

   2013 - Forschungsinformationssystem des UKE